Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:MOGSECHealthcare
Clear all filters
Spooked by Iran war? 7 stocks that are predicted to double investor wealth over next 12 months
positive
ET Markets - Stocks 121d ago

Spooked by Iran war? 7 stocks that are predicted to double investor wealth over next 12 months

Analysts predict significant gains for seven Indian stocks in the next year. Allcargo Logistics, Tarsons Products, Ugro Capital, Awfis Space Solutions, and Puravankara are among those expected to see substantial growth. These projections are based on broker estimates and analyst price targets. Investors can explore these opportunities for potential wealth creation.

ALLCARGOAWFISCPCAPMOGSECPURVASJLOGISTICTARSONSUGROCAPWEALTHFinancial ServicesHealthcare
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy and sell today - 10 March 2026
positive
LiveMint - Markets 123d ago

Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy and sell today - 10 March 2026

Shares to buy or sell: Chandan Taparia has recommended two stocks to buy today, 10 March 2026, and one stock to sell. Taparia recommends buying Torrent Pharmaceuticals and MCX shares today, while selling Maruti Suzuki stock futures.

CHANDANMARUTIMCXMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUETORNTPHARMAutomobile and Auto ComponentsFinancial Services
NEWS
positive
Google News - India Markets 123d ago

Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy and sell today - 10 March 2026 - Mint

Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy and sell today - 10 March 2026Mint

CHANDANMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
CIDCO plans 120-acre commercial hub in Navi Mumbai, floats tender for 20-year development
positive
ET Markets - Industry 124d ago

CIDCO plans 120-acre commercial hub in Navi Mumbai, floats tender for 20-year development

CIDCO has invited bids to develop a 120-acre International Corporate Park in Navi Mumbai's Kharghar, aiming to create a new business district akin to BKC. This initiative, under the state's Theme-Based policy, seeks a private developer via competitive bidding to foster a world-class corporate ecosystem and boost Navi Mumbai's economic growth.

MOGSECPARKHOSPSFinancial ServicesHealthcare
PE Firm True North Sells 3.6% Stake In Anthem Biosciences For Rs 1,261 Crore
positive
NDTV Profit 124d ago

PE Firm True North Sells 3.6% Stake In Anthem Biosciences For Rs 1,261 Crore

HDFC Mutual Fund (MF) and SBI MF have collectively acquired 93,01,020 shares or 1.65% holding in Anthem Biosciences at an average price of Rs 621.10 apiece.

ABSLPSEALPHAALPHAETFANTHEMAONEGOLDAONELIQUIDAONENIFTYAONETOTALAUTOBEESAUTOIETFAXISBPSETFBANKADDBANKBETFBANKETFBANKPSUBBETF0432BBNPNBETFBBNPPGOLDBFSIBNKETFAXISCHEMICALCHOICEGOLDCOMMOIETFCONSUMAXISDEFENCEDIVIDENDEBANKNIFTYEBBETF0430EBBETF0431EBBETF0433ECAPINSUREEGOLDELIQUIDELM250ENERGYENIFTYEQUAL200EQUAL50EQUAL50ADDESENSEXESGESILVERFINIETFFLEXIADDFMCGIETFGILT10BETAGILT5BETAGOLD1GOLD360GOLDADDGOLDAXISGOLDBETAGOLDBNDGOLDETFGROWWCAPMGROWWCHEMGROWWDEFNCGROWWEVGROWWGOLDGROWWHOSPIGROWWLIQIDGROWWLOVOLGROWWMC150GROWWMETALGROWWMOM50GROWWN200GROWWNETGROWWNIFTYGROWWNXT50GROWWPOWERGROWWPSEGROWWRAILGROWWRLTYGROWWSC250GROWWSLVRGSEC10IETFGSEC10YEARHDFCGOLDHDFCGROWTHHDFCLOWVOLHDFCMID150HDFCMOMENTHDFCNEXT50HDFCNIF100HDFCNIFITHDFCPSUBKHDFCPVTBANHDFCQUALHDFCSILVERHDFCSML250HDFCVALUEHEALTHADDHEALTHAXISHEALTHCAREHEALTHIETFICICIB22INFRAIETFINTERNETITADDITAXISITBEESITBETAITETFITIETFLICNETFSENLICNMID100LIQGRWBEESLIQUIDLIQUID1LIQUIDPLUSLIQUIDSBILIQUIDSHRILOWVOLMAFANGMAHKTECHMAKEINDIAMANUFGBEESMASPTOP50METALMETALIETFMID150MIDCAPADDMIDCAPBETAMIDCAPETFMIDCAPIETFMIDQ50ADDMNCMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM30IETFMOM50MOMENTUMMOMENTUM30MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTOURMOVALUEMSCIADDMSCIINDIAMULTICAPNEXT30ADDNEXT50NEXT50ADDNEXT50BETANEXT50ETFNEXT50IETFNIFTY100EWNIFTYADDNIFTYAXISNIFTYBETFNIFTYETFNIFTYQLITYOILIETFPHARMABEESPSUBANKADDPSUBNKIETFPVTBANKADDQUALITY30SBIBPBSBIETFCONSBIETFITSBIETFPBSBIETFQLTYSBILIQETFSBINEQWETFSBISILVERSELECTIPOSENSEXAXISSENSEXETFSETF10GILTSILVERSILVER1SILVER360SILVERADDSILVERAGSILVERAXISSILVERBEESSILVERBETASILVERBNDSILVERIETFSMALL250SMALLADDSNXT30BEESTATAGOLDTATSILVTECHTNIDETFTOP10ADDTOP20TWCGOLDETFUNIONGOLDVAL30IETFVALUEAXISFinancial ServicesHealthcare
Laurus Labs shares are up 100% in the last 12 months and Motilal Oswal sees further upside
positive
CNBC TV18 - Markets 135d ago

Laurus Labs shares are up 100% in the last 12 months and Motilal Oswal sees further upside

Motilal Oswal expects Laurus Labs to end financial year 2026 with a Profit After Tax (PAT) of ₹850 crore and reach ₹1,150 crore by financial year 2028, implying a Compounded Annual Growth Rate (CAGR) of 16% by this period.

AONELIQUIDCASHIETFHDFCLIQUIDJMFINANCILLAURUSLABSLIQGRWBEESLIQUIDBETFLIQUIDPLUSMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESBILIQETFFinancial ServicesHealthcare
Sanofi Consumer Healthcare shares zoom 14% after Q4 profit jumps 50%; declares dividend of Rs 75
positive
ET Markets - Stocks 135d ago

Sanofi Consumer Healthcare shares zoom 14% after Q4 profit jumps 50%; declares dividend of Rs 75

Sanofi Consumer Healthcare shares surged over 14% following a robust 50% year-on-year net profit increase to Rs 66.5 crore in Q4. Driven by product relaunches and strong export growth, the company reported a 47% revenue jump. Full-year profit rose 33%, prompting a Rs 75 per share dividend payout.

CONSUMERDIVIDENDHCGHEALTHCAREMOGSECSANOFISANOFICONRFinancial ServicesHealthcare
Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026
neutral
LiveMint - Markets 141d ago

Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026

Shares to buy or sell: Chandan Taparia has recommended two stocks to buy today, 20 February 2026 - Oil and Natural Gas Corporation (ONGC) and RBL Bank shares - and has suggested selling Info Edge (India) stock futures.

BANKINDIACHANDANMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUENAUKRIOILOILIETFONGCRBLBANKConsumer ServicesFinancial Services
NEWS
neutral
Google News - India Markets 141d ago

Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026 - Mint

Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026Mint

CHANDANMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
PSL offloads 0.6% stake in Sun Pharma Advanced Research, Motilal Oswal buys additional 0.7% stake in Adisoft
positive
Moneycontrol NaNd ago

PSL offloads 0.6% stake in Sun Pharma Advanced Research, Motilal Oswal buys additional 0.7% stake in Adisoft

Sun Pharma Advanced Research Company shares fell 3.72 percent to Rs 143.04 amid high volumes

ADISOFTMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESPARCCapital GoodsFinancial Services
Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal

Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 2610 in its research report dated June 01, 2026.

GLENMARKMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESPARCFinancial ServicesHealthcare
Stocks to Watch Today: NLC India, IRB Infrastructure, Rail Vikas Nigam, JNK India, Bharti Airtel, Vodafone Idea, NRB Bearings in focus on 09 June
positive
Moneycontrol NaNd ago

Stocks to Watch Today: NLC India, IRB Infrastructure, Rail Vikas Nigam, JNK India, Bharti Airtel, Vodafone Idea, NRB Bearings in focus on 09 June

Stocks to Watch, 09 June: Stocks like NLC India, IRB Infrastructure Developers, Panacea Biotec, Grasim Industries, HCL Technologies, Rail Vikas Nigam, JNK India, Motilal Oswal Financial Services, and NRB Bearings will be in focus on June 9.

BHARTIARTLFOCUSGRASIMHCLTECHIDEAIRBJMFINANCILJNKINDIAMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUENIBLNLCINDIAPANACEABIORVNLCapital GoodsConstruction